Chimeric Receptor mRNA Transfection as a Tool to Generate Antineoplastic Lymphocytes

By P. Rabinovich, M. Komarovskaya, Stephen H. Wrzesinski, Jonathan L. Alderman, T. Budak-Alpdogan, A. Karpikov, Hongfeng Guo, R. Flavell, N. Cheung, S. Weissman and 1 more. 2008

62 citations recorded by the source corpus.

Subfields: Immunology, Molecular Biology, Oncology

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. James J. Collins
2. Derrick J. Rossi

In Molecular Biology

1. Yuin Han Loh
2. Alexander Meissner
3. G. Daley
4. James J. Collins
5. Zachary D. Smith
6. Derrick J. Rossi
7. S. Yamanaka
8. Dongbin Xiu

In Oncology

1. James J. Collins

Citations in the corpus

• Highly efficient reprogramming to pluripotency and directed differentiation of human cells using synthetic modified mRNA (2010, background): “Indeed, the use of RNA transfection to express cancer or pathogen antigens for immunotherapy is already an active research area (Rabinovich et al., 2006, 2008; Van den Bosch et al., 2006; Weissman et al., 2000), and such approaches may benefit from the nonimmunogenic properties of modified RNAs.”